DalsnaFinance › IPOs › Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. completed its initial public offering on NASDAQ on June 7, 2024, pricing at $17.00 a share.
| Ticker | RAPP |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 7, 2024 |
| Offering price | $17.00 |
| Shares offered | 8,000,000 |
| Total raised | $136M |
Rapport Therapeutics, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.